101 related articles for article (PubMed ID: 2625740)
21. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
Camici M; Sagripanti A; Barsotti G; Baicchi U; Evangelisti L; Morelli E; Giovannetti S
Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
[TBL] [Abstract][Full Text] [Related]
22. [Plasma and urinary antithrombin III in the nephrotic syndrome in adults].
Antelin CH; Gouault-Heilmann M; Levent M; Bernard D; Ruszniewski P; Lagrue G
Ann Med Interne (Paris); 1983; 134(8):713-6. PubMed ID: 6666909
[TBL] [Abstract][Full Text] [Related]
23. [The changes and relation among platelet function, plasma heparin and anti-coagulation-III: activity in patients with hemorrhagic fever with renal syndrome].
Wei L; Pan X; Yu Y; Lu Q
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Jun; 11(2):163-5. PubMed ID: 15619827
[TBL] [Abstract][Full Text] [Related]
24. [Acute effects of sulodexide on the lipid profile and on antithrombin III in patients with chronic renal insufficiency in hemodialysis treatment].
Averna MR; Citarella P; Picone F; Capodicasa G; Galione A; Rini G; Notarbartolo A
Clin Ter; 1984 Jan; 108(2):111-4. PubMed ID: 6232045
[No Abstract] [Full Text] [Related]
25. [A method of determining heparin in blood plasma based on its antithrombin activity].
Taktashev RE; Suvorova AV; Miller VE; Kolesnikova OI
Lab Delo; 1990; (12):59-61. PubMed ID: 1710698
[TBL] [Abstract][Full Text] [Related]
26. [Anticoagulating activity and lytic action of the heparin-antithrombin III and antithrombin III-heparin-thrombin complexes on non-stabilized fibrin].
Kudriashov BA; Pastorova VE; Liapina LA
Biokhimiia; 1981 Nov; 46(11):2024-9. PubMed ID: 7317530
[TBL] [Abstract][Full Text] [Related]
27. [Automated simultaneous measurements of activity and antigenicity of plasma antithrombin III].
Tsushima C; Chiba H; Akizawa K; Araki K; Matsuno K; Kobayashi K
Rinsho Byori; 1994 Jul; 42(7):713-7. PubMed ID: 8065037
[TBL] [Abstract][Full Text] [Related]
28. [Studies on antithrombin III. I. Purification and some properties of antithrombin III (ATIII), and the relationship between plasma antithrombin activity and ATIII antigen concentration (author's transl)].
Takahashi K
Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):879-88. PubMed ID: 7234301
[No Abstract] [Full Text] [Related]
29. Lipoprotein fractions and antithrombin III consumption during clotting.
Winter JH; Bennett B; McTaggart F; Douglas AS
Thromb Haemost; 1982 Jun; 47(3):236-8. PubMed ID: 7112497
[TBL] [Abstract][Full Text] [Related]
30. [Antithrombin III substitution in dialysis-dependent renal insufficiency].
Schrader J; Köstering H; Kramer P; Scheler F
Dtsch Med Wochenschr; 1982 Dec; 107(48):1847-50. PubMed ID: 7140568
[TBL] [Abstract][Full Text] [Related]
31. Antithrombin III Alger: a new homozygous AT III variant.
Fischer AM; Cornu P; Sternberg C; Mériane F; Dautzenberg MD; Chafa O; Beguin S; Desnos M
Thromb Haemost; 1986 Apr; 55(2):218-21. PubMed ID: 3715788
[TBL] [Abstract][Full Text] [Related]
32. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
Hoylaerts M; Holmer E; de Mol M; Collen D
Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
[TBL] [Abstract][Full Text] [Related]
33. Changes of antithrombin III and antithrombin III-heparin complex levels, and ACT in cardiac surgery.
Inada E; Iwahashi K; Aoki K; Takanashi S; Kohama M; Aoki Y
Can J Anaesth; 1990 May; 37(4 Pt 2):S75. PubMed ID: 2361314
[No Abstract] [Full Text] [Related]
34. Fate of thrombin and thrombin-antithrombin-III complex adsorbed to a heparinized biomaterial: analysis of the enzyme-inhibitor complexes displaced by plasma.
Hatton MW; Rollason G; Sefton MV
Thromb Haemost; 1983 Dec; 50(4):873-7. PubMed ID: 6198746
[TBL] [Abstract][Full Text] [Related]
35. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
Kudrjashov BA; Pastorova VE; Lyapina LA
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
[TBL] [Abstract][Full Text] [Related]
36. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
Mannucci PM; Valsecchi C; Bottasso B; D'Angelo A; Casati S; Ponticelli C
Thromb Haemost; 1986 Feb; 55(1):31-3. PubMed ID: 3754658
[TBL] [Abstract][Full Text] [Related]
37. Effect of hemodialysis on protein C, protein S, and antithrombin III levels.
Lai KN; Yin JA; Yuen PM; Li PK
Am J Kidney Dis; 1991 Jan; 17(1):38-42. PubMed ID: 1824735
[TBL] [Abstract][Full Text] [Related]
38. [Antithrombin III in chronic renal insufficiency].
Bekić-Kaluza S; Macanović M
Med Arh; 1991; 45(1-2):3-8. PubMed ID: 1366314
[TBL] [Abstract][Full Text] [Related]
39. Anticoagulant therapy in a congenital antithrombin III (ATIII)-deficient patient with chronic renal failure undergoing regular hemodialysis.
Matsuo T; Yamada T; Matsuo M; Sakai R
Biomater Artif Cells Immobilization Biotechnol; 1991; 19(1):185-91. PubMed ID: 1751668
[TBL] [Abstract][Full Text] [Related]
40. Studies of the heterogeneity of antithrombin III concentrates.
Barrowcliffe TW; Eggleton CA; Mahmoud M
Br J Haematol; 1983 Sep; 55(1):37-46. PubMed ID: 6882687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
